Thursday, July 9, 2026

pharma · Cancer · PBLS

Parabilis Medicines

Parabilis Medicines patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Villejust, FR HQ
2004 Founded
8 Employees
Public company Type
PBLS · NYSE Ticker
Company details
Status
Public
HQ
Villejust, FR
Founded
2004
Employees
8
Programs
1
Drugs
0
Patents
1
Intelligence · Patents

Parabilis Medicines patents

1 pharmaceutical patents indexed for Parabilis Medicines. 0 expire within 24 months.

Parabilis Medicines has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 12398178

    Collections of peptides, peptide agents, and methods of use thereof

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Parabilis Medicines have?

1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Parabilis Medicines patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.